Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human umbilical cord mesenchymal stem cell transfusion in decompensated liver cirrhosis
ChiCTR1800015304Phase 2Not yet recruiting
- Sponsor
- Jinan Infectious Disease Hospital
- Start
- Apr 2018
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of human umbilical cord mesenchymal stem cells in Cirrhosis (3 arms), sponsored by Jinan Infectious Disease Hospital. Primary endpoint: Overall survival. Planned start Apr 2018; status: not yet recruiting.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on ChiCTR1800015304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015304.